Inconclusive evidence puts Adderall back on the market.
Kondro
Wayne
W
D000662:Amphetamines / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002170:Canada; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D015331:Cohort Studies; D000075202:Contraindications; D003643:Death; D006801:Humans; D012307:Risk Factors
C090411:Adderall; D000662:Amphetamines; D000697:Central Nervous System Stimulants